Anika Therapeutics, Inc. (NASDAQ:ANIK)

CAPS Rating: 3 out of 5

The Company develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.

Recs

0
Player Avatar ZoomAddict111 (< 20) Submitted: 5/8/2008 1:03:13 AM : Outperform Start Price: $10.53 ANIK Score: +31.52

Strong pipeline/partnerships/mgt. Beaten down by econ fears. Hold until it outperforms the market by thirty percent or so. PE when added was 20.2

Report this Post Reply

Featured Broker Partners


Advertisement